Patents by Inventor Simon Molgaard Jensen

Simon Molgaard Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12240921
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Grant
    Filed: May 10, 2024
    Date of Patent: March 4, 2025
    Assignee: Teitur Trophics ApS
    Inventors: Anders Dalby, Simon Mølgaard Jensen, Mathias Kaas Ollendorff, Kristian Strømgaard, Keld Fosgerau
  • Publication number: 20240301005
    Abstract: SorCS2 related lipidated cyclic peptides, cyclic peptides, lipidated linear peptides, linear peptides which may be of use in medicine, and related aspects.
    Type: Application
    Filed: May 10, 2024
    Publication date: September 12, 2024
    Inventors: Anders DALBY, Simon Mølgaard JENSEN, Mathias Kaas OLLENDORFF, Kristian STRØMGAARD, Keld FOSGERAU
  • Publication number: 20230312652
    Abstract: The present invention concerns novel cyclic peptides, and medical uses thereof, such as treatment and/or prevention of diseases of the nervous system, neuropathic pain, and/or mental and behavioural disorders, and related aspects.
    Type: Application
    Filed: August 6, 2021
    Publication date: October 5, 2023
    Inventors: Simon Mølgaard Jensen, Simon Glerup Pedersen, Anders Dalby
  • Publication number: 20190345216
    Abstract: The present invention concerns compounds and methods for modulating the phosphorylation of the Vps10 domain-containing receptor SorCS2, SorCS1 or SorCS3, and/or expression thereof. By said modulation the invention is useful for treatment and amelioration of neurological, mental and behavioural, metabolic, eating, and neoplastic disorders.
    Type: Application
    Filed: December 19, 2016
    Publication date: November 14, 2019
    Inventors: Simon Molgaard Jensen, Simon Glerup Pedersen